Rain Oncology Inc. Common Stock
RAIN
RAIN was delisted on the 25th of January, 2024.
59 hedge funds and large institutions have $184M invested in Rain Oncology Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 22 increasing their positions, 9 reducing their positions, and 2 closing their positions.
750% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 2
144% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 9
28% more funds holding
Funds holding: 46 → 59 (+13)
9% more capital invested
Capital invested by funds: $169M → $184M (+$15.1M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
41% less call options, than puts
Call options by funds: $720K | Put options by funds: $1.23M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$13.4M |
| 2 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$4.31M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.96M |
| 4 |
GTC
Ghost Tree Capital
New York
|
+$2.31M |
| 5 |
GC
GMT Capital
Atlanta,
Georgia
|
+$1.65M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$23.7M |
| 2 |
PA
Perceptive Advisors
New York
|
-$7.72M |
| 3 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$2.62M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$1.25M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$203K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
UBS Group
Zurich,
Switzerland
| $16.1K | +$8.57K | +927 | +102% |
|
52
Group One Trading
Chicago,
Illinois
| $14.4K | +$15.2K | +1,649 | New |
|
53
Osaic Holdings
Scottsdale,
Arizona
| $11.3K | +$12K | +1,294 | New |
|
|
TC
54
Truvestments Capital
Sarasota,
Florida
| $5.73K | +$6.07K | +656 | New |
|
55
JP Morgan Chase
New York
| $4K | – | – | – |
|
|
GRP
56
Global Retirement Partners
San Rafael,
California
| $3.01K | – | – | – |
|
57
Federated Hermes
Pittsburgh,
Pennsylvania
| $1.45K | +$1.53K | +166 | New |
|
58
Wells Fargo
San Francisco,
California
| $970 | +$388 | +42 | +61% |
|
|
EI
59
Ellevest Inc
New York
| $87 | – | – | – |
|
|
TRCT
60
Tower Research Capital (TRC)
New York
| – | -$11K | -1,408 | Closed |
|
61
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$9 | -1 | -50% |
|
RAIN Hedge Fund Activity: Q1 2023 in Review
59 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Rain Oncology Inc. Common Stock (RAIN) for Q1 2023, worth a combined $184M — up 8.9% from $169M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new RAIN positions and 2 closed out — a net gain of 15 holders — while 22 added to existing stakes and 9 trimmed.
The largest buyer was Adage Capital Partners, adding an estimated $13.4M. The largest seller was Deerfield Management, cutting an estimated $23.7M.
- 59 institutional investors held Rain Oncology Inc. Common Stock (RAIN) as of Q1 2023, up from 46 in Q4 2022.
- Funds reported $184M of Rain Oncology Inc. Common Stock stock for Q1 2023, up 8.9% quarter-over-quarter.
- 17 funds opened new Rain Oncology Inc. Common Stock positions in Q1 2023 and 2 closed out, a net change of +15 holders.
- The largest Rain Oncology Inc. Common Stock buyer in Q1 2023 was Adage Capital Partners, an estimated $13.4M added.
- The largest Rain Oncology Inc. Common Stock seller in Q1 2023 was Deerfield Management, an estimated $23.7M sold.
Based on aggregated 13F filings for Q1 2023.